» Articles » PMID: 25915674

Tooth Extractions in High-risk Patients Under Bisphosphonate Therapy and Previously Affected with Osteonecrosis of the Jaws: Surgical Protocol Supported by Low-level Laser Therapy

Overview
Date 2015 Apr 28
PMID 25915674
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Trauma during dental surgery is a predisposing factor for medication-related osteonecrosis of the jaws (MRONJ). There are no specific guidelines for the management of dental extractions in patients under bisphosphonate therapy (BPT). The authors proposed in 2013 a successful protocol for tooth extractions in patients under BPT supported by Nd:YAG low-level laser therapy (LLLT). The aim of this study was to validate the safety and efficacy of this protocol reporting the data related to its application in a particular category of patients under BPT at high risk for MRONJ and who were previously affected with MRONJ. Eighty-two tooth extractions were performed in 36 patients previously affected with MRONJ. Antibiotic treatment was administered 3 days before and 2 weeks after tooth extractions. Patients were additionally treated with Nd:YAG LLLT, 5 applications of 1 minute each. Patients were evaluated 3 days and once a week for 2 months after the extractions and every time they received LLLT. In a total of 82 extractions, minimal bone exposure was observed in 2 cases, treated with Er:YAG laser vaporization and then completely healed. The data confirmed that laser biostimulation is a reliable technique that can be considered in the surgical protocol for patients under BPT.

Citing Articles

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials.

Hanna R, Miron I, Dalvi S, Arany P, Bensadoun R, Benedicenti S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204116 PMC: 11357434. DOI: 10.3390/ph17081011.


Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.

Scribante A, Ghizzoni M, Pellegrini M, Pulicari F, Spadari F Medicina (Kaunas). 2023; 59(5).

PMID: 37241204 PMC: 10221057. DOI: 10.3390/medicina59050972.


The Role of Dental Practitioners in the Management of Oncology Patients: The Head and Neck Radiation Oncology Patient and the Medical Oncology Patient.

Owosho A, DeColibus K, Hedgepeth B, Wood B, Sansoni R, Gleysteen J Dent J (Basel). 2023; 11(5).

PMID: 37232787 PMC: 10217705. DOI: 10.3390/dj11050136.


Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review.

Hsu K, Hsiao S, Chen P, Chen H, Chen C J Clin Med. 2021; 10(19).

PMID: 34640498 PMC: 8509137. DOI: 10.3390/jcm10194480.


Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report.

Monteiro L, Vasconcelos C, Pacheco J, Salazar F J Clin Exp Dent. 2021; 13(6):e626-e629.

PMID: 34188771 PMC: 8223153. DOI: 10.4317/jced.58323.